|
Market Closed -
Nasdaq
01:30:00 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 22.28 USD | -2.28% |
|
-6.23% | +34.95% |
| 05/09 | Denali Therapeutics Insider Sold Shares Worth $261,929, According to a Recent SEC Filing | MT |
| 25/08 | B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating | MT |
| Market Cap | 356.14Cr 306.28Cr 288.07Cr 262.96Cr 491.8Cr 34TCr 493.4Cr 3.42TCr 1.32TCr 17TCr 1.34TCr 1.31TCr 55TCr | P/E 2026 * |
-9.62x | P/E 2027 * | -9.66x |
|---|---|---|---|---|---|
| Enterprise Value | 285.3Cr 245.36Cr 230.77Cr 210.66Cr 393.98Cr 27TCr 395.25Cr 2.74TCr 1.06TCr 14TCr 1.07TCr 1.05TCr 44TCr | EV / Sales 2026 * |
56.8x | EV / Sales 2027 * | 22.2x |
| Free-Float |
90.03% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DNLI | Delayed | |
CBOE
| DNLI | Real-time | |
|
Tradegate
| 4DN | Real-time | |
|
Boerse Muenchen
| 4DN | Real-time | |
|
Deutsche Boerse AG
| 4DN | Delayed | |
|
Börse Stuttgart
| 4DN | Delayed |
Last Transcript : Denali Therapeutics Inc.
| 1 day | -2.28% | ||
| 1 week | -6.23% | ||
| Current month | -6.23% | ||
| 1 month | -10.27% | ||
| 3 months | +14.14% | ||
| 6 months | +13.15% | ||
| Current year | +34.95% |
| 1 week | 22.14 |  | 23.86 |
| 1 month | 22.14 | | 25.7 |
| Current year | 15.34 | | 27.3 |
| 1 year | 12.58 | | 27.3 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 56.08 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 01/05/2022 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 01/08/2015 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | 58 | 06/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 01/03/2015 |
Jay Flatley
BRD | Director/Board Member | 73 | 01/04/2015 |
David Schenkein
BRD | Director/Board Member | 68 | 01/04/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Sell | Founder | -2,768 | 0.0017% | ||
| 12/08/26 | Don | Founder | -32,220 | 0.0203% | ||
| 11/08/26 | Sell | Founder | -2,857 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.28% | -6.23% | +44.39% | -7.86% | 356.14Cr | |
| -0.38% | -0.99% | +42.69% | +100.85% | 6.8TCr | |
| -2.71% | -0.71% | +35.89% | +81.43% | 6.49TCr | |
| -0.31% | +3.67% | -12.96% | +374.95% | 2.76TCr | |
| +0.86% | +2.12% | -7.74% | -13.34% | 2.61TCr | |
| -0.54% | -2.55% | +23.70% | +12.93% | 2.57TCr | |
| -1.11% | +0.90% | +22.24% | -18.50% | 2.01TCr | |
| +1.15% | -5.02% | +219.82% | +379.02% | 1.72TCr | |
| -1.55% | -1.43% | -8.30% | +518.18% | 1.49TCr | |
| -0.20% | +8.00% | +55.78% | +167.98% | 1.46TCr | |
| Average | -0.71% | +0.17% | +41.55% | +159.57% | 2.83TCr | |
| Weighted average by Cap. | -0.84% | +0.37% | +36.63% | +137.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.03Cr 4.32Cr 4.06Cr 3.71Cr 6.94Cr 475.28Cr 6.96Cr 48Cr 19Cr 243.39Cr 19Cr 18Cr 775.27Cr | 13Cr 11Cr 10Cr 9.37Cr 18Cr 1.2TCr 18Cr 121.69Cr 47Cr 614.52Cr 48Cr 47Cr 1.96TCr |
| Net income | -45Cr -39Cr -37Cr -34Cr -63Cr -4.3TCr -63Cr -435.85Cr -168.47Cr -2.2TCr -170.67Cr -166.94Cr -7.01TCr | -45Cr -39Cr -37Cr -33Cr -62Cr -4.28TCr -63Cr -434.02Cr -167.76Cr -2.19TCr -169.95Cr -166.23Cr -6.98TCr |
| Net Debt | -71Cr -61Cr -57Cr -52Cr -98Cr -6.7TCr -98Cr -679.4Cr -262.61Cr -3.43TCr -266.04Cr -260.22Cr -11TCr | -75Cr -64Cr -61Cr -55Cr -103.39Cr -7.08TCr -103.72Cr -718.03Cr -277.55Cr -3.63TCr -281.16Cr -275.01Cr -12TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | $22.28 | -2.28% | 7,99,633 |
| 03/26/03 | $22.80 | -0.22% | 17,27,981 |
| 02/26/02 | $22.85 | -1.78% | 17,68,603 |
| 01/26/01 | $23.27 | -2.08% | 14,31,668 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNLI Stock
Select your edition
All financial news and data tailored to specific country editions
